Search results
AGF Management Ltd. Buys New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 4 hours agoAGF Management Ltd. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report ...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 6 days ago(NASDAQ:REGN), then you'll have to look at the makeup of its share registry. With 85% stake,...
Examining the Potential Price Growth of Regeneron Pharmaceuticals, Inc.
Knox Daily· 1 day agoAs a result of the transaction, McCourt Marion now holds 13,181 shares, worth roughly $12.98 million. Bernstein initiated its Regeneron Pharmaceuticals, ...
Regeneron CEO Leonard Schleifer sells over $35 million in company stock By Investing.com
Investing.com· 15 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported several transactions by its...
...Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis...
Benzinga· 3 days agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has ...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 2 hours agoSome are better at it than others. Eli Lilly (NYSE: LLY) and Regeneron Pharmaceuticals (NASDAQ: REGN...
...You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years - Regeneron...
Benzinga· 2 days agoRegeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 12.78%. Currently, ...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks· 6 days agoMaking its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) provides investors broad exposure to the Health Care ETFs ...
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Zacks via Yahoo Finance· 2 days agoBayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for...
FDA considers Dupixent for adolescent sinusitis treatment By Investing.com
Investing.com· 3 days ago(NASDAQ: REGN) and Sanofi (NASDAQ:SNY). This review is for Dupixent as an add-on maintenance...